Source: MarketScreener

Soligenix: Soligenix Announces Publication of Positive Pre-clinical Results for a Novel COVID-19 Vaccine

( PRINCETON, N.J., July 28, 2020 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today publication of pre-clinical immunogenicity studies for its CiVax program , demonstrating immunity...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Christopher J. Schaber's photo - President & CEO of Soligenix

President & CEO

Christopher J. Schaber

CEO Approval Rating


Soligenix develops and commercializes biotherapeutics for the treatment of gastrointestinal disorders, inflammation and oncology diseases. Read more